UNH
NEW YORK STOCK EXCHANGE, INC. · Health Care
UnitedHealth Group Inc
$276.65
+8.10 (+3.02%)
UNH News7 articles
UnitedHealth Gains Amid Market Rout as Medicare Advantage Deadlines Loom
UnitedHealth shares advanced nearly 2% on Thursday, defying a broad market decline, as attention turned to key Medicare Advantage policy deadlines and a profit warning from peer Humana.
UnitedHealth Gains Amid Medicare Rate Uncertainty and ACA Investigations
UnitedHealth shares edged higher as investors monitored upcoming Medicare Advantage payment decisions and a House Republican probe into ACA insurers. The sector traded mixed.
UnitedHealth Dips After Hours as Medicare Rate Decision Looms
UnitedHealth shares edged lower in extended trading Monday as healthcare stocks underperformed the broader market. Investors are focused on upcoming Medicare Advantage reimbursement updates, with the final rates expected in early April.
UnitedHealth Shares Edge Higher Amid Medicare Rate Scrutiny and Broader Market Volatility
UnitedHealth Group stock rose slightly as investors assessed a modest proposed Medicare Advantage payment increase for 2027. The healthcare giant continues to navigate pressure following a significant revenue warning earlier this year.
UnitedHealth Rallies 3% to Close Volatile Week; Medicare Advantage Outlook in Focus
UnitedHealth shares gained 3% Friday to $276.65, stabilizing after a turbulent period for managed-care stocks. Investors now await earnings from CVS Health and Humana next week for critical updates on Medicare Advantage trends.
UnitedHealth Rebounds 3% as Managed Care Sector Weighs Diverging Cost Outlooks
UnitedHealth shares rose 3% to $276.65 Friday, recovering after Molina Healthcare's weak 2026 forecast pressured the sector. Investors now await Humana's results and a key Medicare Advantage rate decision.
Healthcare Sector Sees Divergence: Molina Plunges on Outlook, XLV Gains Amid Regulatory Warnings
Molina Healthcare plummeted 25.5% after slashing its 2026 profit forecast and announcing a Medicare Part D exit, while the Health Care Select Sector SPDR Fund (XLV) rose 1.8%. Regulatory warnings on compounded obesity drugs added pressure to the sector.